The Current Ratio of BrightGene Bio-Medical Technology Co Ltd (688166.SS) is 1.56.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 1.56 |
| 2023-12-31 | 1.99 |
| 2022-12-31 | 2.39 |
| 2021-12-31 | 1.70 |
| 2020-12-31 | 3.24 |
| 2019-12-31 | 9.82 |
| 2018-12-31 | 5.33 |
| 2017-12-31 | 3.80 |
| 2016-12-31 | 1.28 |